{
    "clinical_study": {
        "@rank": "57044", 
        "arm_group": [
            {
                "arm_group_label": "Group AB", 
                "arm_group_type": "Active Comparator", 
                "description": "Group AB; (n= 62) received \u03b22-agonists + Ipratropium bromide in nebulization"
            }, 
            {
                "arm_group_label": "Group B", 
                "arm_group_type": "Experimental", 
                "description": "Group B (n= 44) received \u03b22-agonists alone in nebulization"
            }
        ], 
        "brief_summary": {
            "textblock": "The effectiveness of \u03b22-agonists in the treatment of exacerbations of COPD is already\n      established. The purpose of this study is to compare the effectiveness of the \u03b22-agonists\n      alone in nebulization with the association \u03b22-agonists  + Ipratropium bromide  in the\n      treatment of an acute exacerbation of COPD consulting  the emergency departement based on\n      the clinical and the aarterial blood gas."
        }, 
        "brief_title": "\u03b22-agonist Versus Ipratropium Bromide Associated With \u03b22-agonists in Chronic Obstructive Pulmonary Disease Exacerbation", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease Exacerbation", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Disease Progression", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "It is a prospective study and randomized practiced in patients consulting the emergency\n      departement for an acute exacerbation of COPD. The patients were divided in two groups:\n      Group AB; received \u03b22-agonists + Ipratropium bromide in nebulization and Group B received\n      \u03b22-agonists alone in nebulization)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  have known or suspected COPD based on pulmonary function test, arterial blood gas,\n             clinical history, physical examination, and chest radiograph\n\n          -  Age over 18 years old.\n\n          -  COPD Exacerbation: FR>25c/min PaCO2>6Kpa PH<7,35 SaO2<90%\n\n        Exclusion Criteria:\n\n          -  GCS \u2264 12\n\n          -  hypersensitivity to anticholinergic\n\n          -  severe acidosis\n\n          -  lack of patient cooperation\n\n          -  serious heart arrhythmia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01944033", 
            "org_study_id": "\u03b22-agonist"
        }, 
        "intervention": {
            "arm_group_label": [
                "Group AB", 
                "Group B"
            ], 
            "intervention_name": "Drug: Ipratropium bromide", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Bromides", 
                "Ipratropium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "\u03b22-agonist", 
            "Ipratropium Bromide", 
            "Chronic Obstructive Pulmonary Disease Exacerbation", 
            "Emergency departement"
        ], 
        "lastchanged_date": "September 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Monastir,", 
                        "country": "Tunisia", 
                        "state": "Monastir", 
                        "zip": "5000"
                    }, 
                    "name": "University Hospital of Monastir"
                }, 
                "status": "Completed"
            }, 
            {
                "contact": {
                    "email": "semir.nouira@rns.tn", 
                    "last_name": "Nouira Semir, MD", 
                    "phone": "216 73532014"
                }, 
                "facility": {
                    "address": {
                        "city": "Monastir", 
                        "country": "Tunisia", 
                        "zip": "5000"
                    }, 
                    "name": "Fattouma Bourguiba University Hospital"
                }, 
                "investigator": {
                    "last_name": "Nouira Semir, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Tunisia"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "semir.nouira@rns.tn", 
            "last_name": "nouira semir, MD", 
            "phone": "216073460144"
        }, 
        "overall_official": {
            "affiliation": "University of Monastir", 
            "last_name": "semir nouira, Pr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Tunisia: Ministry of Public Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "hospital admission and death rate", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours"
            }, 
            {
                "measure": "hospital admission rate and death rate", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours after ED admission"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01944033"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Monastir", 
            "investigator_full_name": "Nouira", 
            "investigator_title": "Semir Nouira", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "dyspnea score", 
            "safety_issue": "Yes", 
            "time_frame": "120 minutes"
        }, 
        "source": "University of Monastir", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Monastir", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}